Literature DB >> 19590158

Effects of inhalation of thermal water on exhaled breath condensate in chronic obstructive pulmonary disease.

Gabriella Guarnieri1, Silvia Ferrazzoni, Maria Cristina Scarpa, Alberto Lalli, Piero Maestrelli.   

Abstract

BACKGROUND: Inhalation of thermal water (TW) is traditionally used as part of the treatment of chronic obstructive pulmonary disease (COPD), but its benefit and mechanisms are controversial. We previously observed a reduced proportion of neutrophils in induced sputum after treatment with TW.
OBJECTIVES: The aim of this study was to determine whether inhalation of TW in COPD patients is associated with biochemical changes of airway lining fluid, including a reduction in the neutrophil chemoattractant leukotriene B(4) (LTB(4)).
METHODS: Thirteen COPD patients were randomly assigned to receive a 2-week course of TW and normal saline inhalation in a cross-over, single-blind study design. Exhaled breath condensate (EBC) was collected before and after treatments. LTB(4) concentrations in EBC were determined by ELISA, and EBC pH was measured before and after argon deaeration.
RESULTS: No significant differences in LTB(4) concentrations in EBC were detected with either treatment. A significant decrease in pH of non-deaerated EBC was observed after a standard course of TW (median 7.45, interquartile range 6.93-7.66, vs. median 6.99, interquartile range 6.57-7.19; p = 0.05), which disappeared after argon deaeration.
CONCLUSIONS: There is no evidence that TW treatment affects LTB(4) concentration in EBC. The results of EBC pH measurements suggest that TW inhalation induces an imbalance of volatile components of the buffer system in airway lining fluid. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590158     DOI: 10.1159/000227801

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

Review 1.  Health resort medicine in non-musculoskeletal disorders: is there evidence of its effectiveness?

Authors:  Marita Stier-Jarmer; Sandra Kus; Dieter Frisch; Carla Sabariego; Angela Schuh
Journal:  Int J Biometeorol       Date:  2015-01-21       Impact factor: 3.787

2.  Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: a randomised controlled trial on the effects of sulphurous thermal water inhalation.

Authors:  Marco Contoli; Giulia Gnesini; Giacomo Forini; Brunilda Marku; Alessia Pauletti; Anna Padovani; Paolo Casolari; Liliana Taurino; Andrea Ferraro; Milva Chicca; Adalberto Ciaccia; Alberto Papi; Silvano Pinamonti
Journal:  ScientificWorldJournal       Date:  2013-12-23

3.  Medicinal clays improve the endurance of loaded inspiratory muscles in COPD: a randomized clinical trial of nonpharmacological treatment.

Authors:  Simonetta Baldi; Gian Domenico Pinna; Claudio Bruschi; Fabrizio Caldara; Roberto Maestri; Elena Dacosto; Antonella Rezzani; Ermanno Popovich; Ezio Bellinzona; Paola Crotti; Silvia Montemartini; Claudio Fracchia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.